Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the class of p-toluenesulfonamides, characterized by a sulfonamide group attached to a propyl chain and further linked to a pyridin-4-ylcarbamate moiety. It has the molecular formula C16H19N3O4S and a monoisotopic mass of 349.10962 Da. The compound is listed as experimental with no approved medical indications or clinical trial activity reported. Its mechanism of action, pharmacological targets, therapeutic potential, and developer information are not available in public databases[1][2][8]. There is no evidence that it has reached any stage of clinical development or commercialization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate.